NM_000070.3:c.2362_2363delAGinsTCATCT
Variant summary
Our verdict is Pathogenic. Variant got 12 ACMG points: 12P and 0B. PP1PM2_SupportingPP4_StrongPM3_StrongPVS1_Moderate
This summary comes from the ClinGen Evidence Repository: The NM_000070.3: c.2362_2363delinsTCATCT p.(Arg788SerfsTer14) variant in CAPN3 is a frameshift variant predicted to cause a premature stop codon in biologically relevant exon 23/24 that may cause loss of function of the protein, however, it is predicted to escape nonsense mediated decay and remove <10% of the protein (PVS1_Moderate). This variant has been detected in at least 30 individuals with limb girdle muscular dystrophy, including in a homozygous state in one patient (0.5 pts, PMID:18337726), in trans with a pathogenic variant in at least one patient (c.643_663del p.(Ser215_Gly221del), 1.0 pt, PMID:9150160), and in unknown phase with a pathogenic variant (c.223dup p.(Tyr75LeufsTer5), 0.5 pts, PMID:30564623, LOVD Individual #00220184) (PM3_Strong). At least one patient with this variant displayed a clinical suspicion of limb girdle muscular dystrophy and absent expression of calpain-3, which is highly specific for CAPN3-related LGMD (PP4_Strong; PMID:18337726). The variant has also been reported to segregate with LGMD in one affected family member (PP1; PMID:9150160). This variant is absent from gnomAD v2.1.1 and v3.1.2 (PM2_Supporting). In summary, this variant meets the criteria to be classified as Pathogenic for autosomal recessive limb girdle muscular dystrophy based on the ACMG/AMP criteria applied, as specified by the ClinGen LGMD VCEP (LGMD VCEP specifications version 1.0.0; 01/09/2025): PVS1_Moderate, PM3_Strong, PP4_Strong, PP1, PM2_Supporting. LINK:https://erepo.genome.network/evrepo/ui/classification/CA127307/MONDO:0015152/187
Frequency
Consequence
NM_000070.3 frameshift, missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 12 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CAPN3 | ENST00000397163.8 | c.2362_2363delAGinsTCATCT | p.Arg788SerfsTer14 | frameshift_variant, missense_variant | Exon 22 of 24 | 1 | NM_000070.3 | ENSP00000380349.3 | ||
CAPN3 | ENST00000673886.1 | c.367_368delAGinsTCATCT | p.Arg123SerfsTer14 | frameshift_variant, missense_variant | Exon 9 of 11 | ENSP00000501155.1 | ||||
CAPN3 | ENST00000673928.1 | c.367_368delAGinsTCATCT | p.Arg123SerfsTer14 | frameshift_variant, missense_variant | Exon 9 of 11 | ENSP00000501099.1 | ||||
CAPN3 | ENST00000674146.1 | c.367_368delAGinsTCATCT | p.Arg123SerfsTer14 | frameshift_variant, missense_variant | Exon 10 of 12 | ENSP00000501175.1 | ||||
CAPN3 | ENST00000674149.1 | c.367_368delAGinsTCATCT | p.Arg123SerfsTer14 | frameshift_variant, missense_variant | Exon 9 of 11 | ENSP00000501112.1 | ||||
CAPN3 | ENST00000673743.1 | c.265_266delAGinsTCATCT | p.Arg89SerfsTer14 | frameshift_variant, missense_variant | Exon 9 of 11 | ENSP00000500989.1 | ||||
ENSG00000258461 | ENST00000495723.1 | n.*2798_*2799delAGinsTCATCT | non_coding_transcript_exon_variant | Exon 24 of 26 | 2 | ENSP00000492063.1 | ||||
ENSG00000258461 | ENST00000495723.1 | n.*2798_*2799delAGinsTCATCT | 3_prime_UTR_variant | Exon 24 of 26 | 2 | ENSP00000492063.1 |
Frequencies
GnomAD3 genomes Cov.: 31
GnomAD4 genome Cov.: 31
ClinVar
Submissions by phenotype
not provided Pathogenic:5
- -
- -
Frameshift variant predicted to result in protein truncation, as the last 34 amino acids are replaced with 13 different amino acids, and other loss-of-function variants have been reported downstream in the Human Gene Mutation Database (HGMD); Not observed at significant frequency in large population cohorts (gnomAD); This variant is associated with the following publications: (PMID: 18337726, 10330340, 22194990, 16607617, 18055493, 15757244, 28615891, 9150160, 25900067, 9762961, 12461690, 17236769, 7720071, 16344536, 18563459, 21984748, 28103310, 31011535, 30919934, 31127727, 35741838, 15689361, 30564623) -
The variant results in a shift of the reading frame, and is therefore predicted to result in the loss of a functional protein. Found in at least one symptomatic patient, and not found in general population data. Occurs in three or more cases with a recessive pathogenic variant in the same gene. Strong co-segregation with disease, and data include affected and unaffected individuals from multiple families. -
- -
Autosomal recessive limb-girdle muscular dystrophy type 2A Pathogenic:3Other:1
This sequence change creates a premature translational stop signal (p.Arg788Serfs*14) in the CAPN3 gene. While this is not anticipated to result in nonsense mediated decay, it is expected to disrupt the last 34 amino acid(s) of the CAPN3 protein. Information on the frequency of this variant in the gnomAD database is not available, as this variant may be reported differently in the database. This premature translational stop signal has been observed in individuals with autosomal recessive limb-girdle muscular dystrophy (PMID: 9150160, 18563459, 21984748, 22194990). This variant is also known as 2362AG->TCATCT. ClinVar contains an entry for this variant (Variation ID: 17618). For these reasons, this variant has been classified as Pathogenic. -
- -
- -
Pathogenic variant most likely the result of a founder effect followed by genetic isolation in populations in Guipuzcoa province in the Basque country of Spain, and in Brazil, [Urtasun et al 1998, de Paula et al 2002]. -
Autosomal recessive limb-girdle muscular dystrophy Pathogenic:2
Variant summary: CAPN3 c.2362_2363delinsTCATCT (p.Arg788SerfsX14) results in a premature termination codon, predicted to cause a truncation of the encoded protein or absence of the protein due to nonsense mediated decay, which are commonly known mechanisms for disease. The variant was absent in 251342 control chromosomes (gnomAD). c.2362_2363delinsTCATCT has been reported in the literature in several homozygous- and compound heterozygous individuals affected with Limb-Girdle Muscular Dystrophy, Autosomal Recessive (e.g. Richard_1997, de Paula_2002, Saenz_2005), where muscle biopsy samples derived from multiple homozygote patients demonstrated complete- or partial loss of calpain (see e.g. de Paula_2002, Saenz_2005). These data indicate that the variant is very likely to be associated with disease. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. Five submitters have provided clinical-significance assessments for this variant to ClinVar after 2014, and all classified the variant as pathogenic. Based on the evidence outlined above, the variant was classified as pathogenic. -
The NM_000070.3: c.2362_2363delinsTCATCT p.(Arg788SerfsTer14) variant in CAPN3 is a frameshift variant predicted to cause a premature stop codon in biologically relevant exon 23/24 that may cause loss of function of the protein, however, it is predicted to escape nonsense mediated decay and remove <10% of the protein (PVS1_Moderate). This variant has been detected in at least 30 individuals with limb girdle muscular dystrophy, including in a homozygous state in one patient (0.5 pts, PMID: 18337726), in trans with a pathogenic variant in at least one patient (c.643_663del p.(Ser215_Gly221del), 1.0 pt, PMID: 9150160), and in unknown phase with a pathogenic variant (c.223dup p.(Tyr75LeufsTer5), 0.5 pts, PMID: 30564623, LOVD Individual #00220184) (PM3_Strong). At least one patient with this variant displayed a clinical suspicion of limb girdle muscular dystrophy and absent expression of calpain-3, which is highly specific for CAPN3-related LGMD (PP4_Strong; PMID: 18337726). The variant has also been reported to segregate with LGMD in one affected family member (PP1; PMID: 9150160). This variant is absent from gnomAD v2.1.1 and v3.1.2 (PM2_Supporting). In summary, this variant meets the criteria to be classified as Pathogenic for autosomal recessive limb girdle muscular dystrophy based on the ACMG/AMP criteria applied, as specified by the ClinGen LGMD VCEP (LGMD VCEP specifications version 1.0.0; 01/09/2025): PVS1_Moderate, PM3_Strong, PP4_Strong, PP1, PM2_Supporting. -
Muscular dystrophy, limb-girdle, autosomal dominant 4 Pathogenic:1
- -
Autosomal recessive limb-girdle muscular dystrophy type 2A;C4748295:Muscular dystrophy, limb-girdle, autosomal dominant 4 Pathogenic:1
- -
Myositis, eosinophilic Pathogenic:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at